PMID- 35889886 OWN - NLM STAT- MEDLINE DCOM- 20220728 LR - 20220731 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 14 IP - 14 DP - 2022 Jul 17 TI - Anti-Obesity Effects of Aqueous Extracts of Sunbanghwalmyung-Eum in High-Fat- and High-Cholesterol-Diet-Induced Obese C57BL/6J Mice. LID - 10.3390/nu14142929 [doi] LID - 2929 AB - Sunbanghwalmyung-eum (SBH) is a traditional herbal medicine that exhibits various pharmacological properties, such as antioxidant, anti-inflammatory, and anticancer activities. In this study, we investigated the systemic anti-obesity effects of an aqueous extract of SBH in the liver, adipose, and muscle tissue from high-fat and high-cholesterol diet (HFHCD)-induced obese C57BL/6J mice. After 6 weeks of an HFHCD, the mice were continuously fed HFHC with oral administration of SBH (100 mg/kg/day), Sim (simvastatin, 5 mg/kg/day, positive control), or water (HFHC only) for another 6 weeks. Our results showed that SBH attenuated the HFHCD-induced body weight gain and fat accumulation in the liver, and improved plasma lipid levels, such as those of triglycerides (TGs), blood total cholesterol (TC), and low-density lipoprotein (LDL-c). SBH and Sim inhibited the inflammation accompanied by obesity via decreasing inflammatory cytokine interleukin (IL)-1beta, tumor necrosis factor alpha (TNFalpha), and monocyte chemoattractant protein 1 (MCP1). Moreover, SBH downregulated the expression of protein levels of adipogenic-related factors, including peroxisome proliferator-activated receptor gamma (PPARgamma) and CCAAT/enhancer-binding protein alpha (C/EBPalpha), in the liver, adipose, and muscle tissue. The SBH and Sim treatment also significantly upregulated the phosphorylation of AMP-activated protein kinase alpha (AMPKalpha) in the liver and hormone-sensitive lipase (HSL) in the adipose tissue. Overall, the effects of SBH on HFHCD-induced obesity were similar to or more potent than those of simvastatin. These results indicated that SBH has great potential as a therapeutic herbal medicine for obesity. FAU - Kim, Hye-Lin AU - Kim HL AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Ahn, You Mee AU - Ahn YM AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Lee, So Min AU - Lee SM AUID- ORCID: 0000-0003-3833-6792 AD - KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Seo, Chang-Seob AU - Seo CS AUID- ORCID: 0000-0002-8156-446X AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Park, Seong-Hwan AU - Park SH AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Bang, Ok-Sun AU - Bang OS AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. FAU - Jung, Jeeyoun AU - Jung J AUID- ORCID: 0000-0002-9213-4748 AD - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. LA - eng GR - KSN2022210/Korea Institute of Oriental Medicine/ PT - Journal Article DEP - 20220717 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 0 (Anti-Obesity Agents) RN - 0 (CCAAT-Enhancer-Binding Protein-alpha) RN - 0 (PPAR gamma) RN - 0 (Plant Extracts) RN - 059QF0KO0R (Water) RN - 97C5T2UQ7J (Cholesterol) RN - AGG2FN16EV (Simvastatin) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) SB - IM MH - AMP-Activated Protein Kinases/metabolism MH - Adipogenesis MH - Adipose Tissue/metabolism MH - Animals MH - *Anti-Obesity Agents/therapeutic use MH - CCAAT-Enhancer-Binding Protein-alpha/metabolism MH - Cholesterol/metabolism MH - Diet, High-Fat MH - *Hyperlipidemias/drug therapy MH - Mice MH - Mice, Inbred C57BL MH - Mice, Obese MH - Obesity/metabolism MH - PPAR gamma/metabolism MH - Plant Extracts/therapeutic use MH - Simvastatin/pharmacology MH - Water/metabolism PMC - PMC9318667 OTO - NOTNLM OT - C57BL/6J mice OT - Sunbanghwalmyung-eum OT - high-fat high-cholesterol diet OT - obesity COIS- The authors declare no conflict of interest. EDAT- 2022/07/28 06:00 MHDA- 2022/07/29 06:00 PMCR- 2022/07/17 CRDT- 2022/07/27 01:37 PHST- 2022/06/15 00:00 [received] PHST- 2022/07/08 00:00 [revised] PHST- 2022/07/14 00:00 [accepted] PHST- 2022/07/27 01:37 [entrez] PHST- 2022/07/28 06:00 [pubmed] PHST- 2022/07/29 06:00 [medline] PHST- 2022/07/17 00:00 [pmc-release] AID - nu14142929 [pii] AID - nutrients-14-02929 [pii] AID - 10.3390/nu14142929 [doi] PST - epublish SO - Nutrients. 2022 Jul 17;14(14):2929. doi: 10.3390/nu14142929.